Max Health is delighted to announce that it has received approval from Medsafe regarding the registration of Variquel (Terlipressin) 0.2mg/mL in 5mL solution for Injection for use in New Zealand. This is effective 28 January 2021.
This product is manufactured in Europe and is supplied to Max Health by Alliance.
